Back to results
US 2024/0390501 A1Published application
Colon-targeted active agent delivery carrier and uses thereof
AssigneeAwkeonomic Biotechnology Co., Ltd.
InventorShih-Kuo HOU
Life of this patent
Estimating the term…
Abstract
A colon-targeted active agent delivery carrier includes a low methoxyl pectin derived from Jelly fig (Jelly fig LM pectin) and a divalent cation, wherein the Jelly fig LM pectin crosslinks with the divalent cation in an egg-box conformation, wherein the colon-targeted composition is degraded by at least one enzyme in the colon of the subject to release the active agent.
Claims18
A method for manufacturing a colon-targeted composition, comprising:
- (a) providing an aqueous phase comprising a Jelly fig low methoxyl pectin, an active agent and an insoluble salt of calcium;
- wherein the Jelly fig low methoxyl pectin has the characteristics of:
- (1) an average molecular weight of at least 750,000 daltons;
- (2) an esterification degree of about 31% or less;
- and
- (3) a galacturonic acid content of at least 75% to about 90%;
- (b) mixing the aqueous phase with an oil phase to form a water-in-oil emulsion;
- (c) dripping an acid into the water-in-oil emulsion, such that the insoluble salt of calcium dissolves to release calcium ion, and the Jelly fig low methoxyl pectin crosslinks with calcium ion to form hydrogel composite particles containing the active agent;
- (d) slowly pouring a critical volume of an aqueous solution containing a soluble salt of calcium into the water-in-oil emulsion to solidify the hydrogel composite particles and to separate the water-in-oil emulsion into the aqueous phase and the oil phase, wherein the hydrogel composite particles are in the aqueous phase;
- and
- (e) separating the hydrogel composite particles from the aqueous phase.
8 more elements
Dependencies are inferred from the claim text.